tiprankstipranks
Trending News
More News >
Moleculin Biotech’s Annamycin Pediatric Study Approved by FDA
PremiumCompany AnnouncementsMoleculin Biotech’s Annamycin Pediatric Study Approved by FDA
16d ago
Moleculin Biotech receives FDA feedback on pediatric study plan for Annamycin
Premium
The Fly
Moleculin Biotech receives FDA feedback on pediatric study plan for Annamycin
16d ago
Moleculin Biotech announces ‘What This Means’ virtual investor segment
Premium
The Fly
Moleculin Biotech announces ‘What This Means’ virtual investor segment
23d ago
Moleculin Biotech Stock (MBRX) Dives 10% on Clinical Trial Results
PremiumMarket NewsMoleculin Biotech Stock (MBRX) Dives 10% on Clinical Trial Results
30d ago
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
30d ago
Moleculin Biotech Reports Positive Annamycin Trial Results
Premium
Company Announcements
Moleculin Biotech Reports Positive Annamycin Trial Results
1M ago
Moleculin Biotech’s Growth Potential Highlighted by Phase 3 MIRACLE Trial and Strategic Advancements
PremiumRatingsMoleculin Biotech’s Growth Potential Highlighted by Phase 3 MIRACLE Trial and Strategic Advancements
2M ago
Moleculin Biotech Reports Q1 2025 Financial Results
Premium
Company Announcements
Moleculin Biotech Reports Q1 2025 Financial Results
2M ago
Moleculin Biotech reports Q1 EPS (69c) vs ($2.02) last year
Premium
The Fly
Moleculin Biotech reports Q1 EPS (69c) vs ($2.02) last year
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100